BRKR logo

Bruker (BRKR) Company Overview

Profile

Full Name:

Bruker Corporation

Sector:

Healthcare

Country:

United States

IPO:

August 4, 2000

Indexes:

Not included

Description:

Bruker Corporation is an American company headquartered in Billerica, Massachusetts, specializing in the development, production, and sale of scientific research instruments, analytical and diagnostic solutions that contribute to material research at microscopic, molecular, and cellular levels. The company was founded in 1960. The company's technological platform includes technologies such as magnetic resonance, mass spectrometry, gas and liquid chromatography, triple quadrupole mass spectrometry, X-ray technologies, laser-induced breakdown spectroscopy, atomic force microscopy, optical metrology, fluorescent optical microscopy, and Raman spectroscopy.

Key Details

Price

$56.02

Annual Revenue

$2.96 B(+17.14% YoY)

Annual EPS

$2.90(+45.73% YoY)

Beta

0.88

Events Calendar

Earnings

Next earnings date:

Feb 13, 2025

Recent quarterly earnings:

Nov 5, 2024

Recent annual earnings:

Feb 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Dec 2, 2024
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 17, 25 Guggenheim
Buy
Dec 19, 24 Guggenheim
Buy
Dec 13, 24 B of A Securities
Buy
Dec 5, 24 Goldman Sachs
Neutral
Nov 6, 24 Wells Fargo
Overweight
Nov 6, 24 TD Cowen
Hold
Nov 6, 24 Citigroup
Buy
Nov 6, 24 Barclays
Overweight
Oct 15, 24 Barclays
Overweight
Sep 30, 24 Wolfe Research
Peer Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope
BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope
BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope
BRKR
zacks.comJanuary 14, 2025

Bruker has introduced the LUMOS II ILIM, an infrared microscope that uses QCL technology, aimed at pharmaceutical and life science research.

BRKR Stock Declines Despite Launching EpicIF Technology for CellScape
BRKR Stock Declines Despite Launching EpicIF Technology for CellScape
BRKR Stock Declines Despite Launching EpicIF Technology for CellScape
BRKR
zacks.comNovember 11, 2024

Bruker's latest technology, EpicIF, aims to improve the CellScape Precise Spatial Proteomics platform.

BRKR Misses on Q3 Earnings, Cuts '24 View, Stock Up in Aftermarket
BRKR Misses on Q3 Earnings, Cuts '24 View, Stock Up in Aftermarket
BRKR Misses on Q3 Earnings, Cuts '24 View, Stock Up in Aftermarket
BRKR
zacks.comNovember 7, 2024

Bruker experienced strong revenue growth in the third quarter, even though the overall market conditions were weak.

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress
Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress
Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress
BRKR
globenewswire.comOctober 17, 2024

Biognosys has announced that it will take part in the 23rd Human Proteome Organization (HUPO) World Congress, which will be held in Dresden, Germany, from October 20 to October 24.

Here's Why You Should Retain BRKR Stock in Your Portfolio Now
Here's Why You Should Retain BRKR Stock in Your Portfolio Now
Here's Why You Should Retain BRKR Stock in Your Portfolio Now
BRKR
zacks.comOctober 3, 2024

Bruker's strong growth potential in its Nano segment is promising. However, negative changes in currency exchange rates may create difficulties.

Assessment of the Dermatology Diagnostic Devices Market, 2020-2030, Featuring Strategic Analysis of Canfield Scientific, Leica Microsystems, Welch Allyn, Bruker, Heine Optotechnik & More
Assessment of the Dermatology Diagnostic Devices Market, 2020-2030, Featuring Strategic Analysis of Canfield Scientific, Leica Microsystems, Welch Allyn, Bruker, Heine Optotechnik & More
Assessment of the Dermatology Diagnostic Devices Market, 2020-2030, Featuring Strategic Analysis of Canfield Scientific, Leica Microsystems, Welch Allyn, Bruker, Heine Optotechnik & More
BRKR
globenewswire.comSeptember 20, 2024

Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com has released a new report titled "Dermatology Diagnostic Devices Market (2024 Edition)," which analyzes the market by device type, application, end-user, and region, providing insights and forecasts from 2020 to 2030. The report covers the growth of the Global Dermatology Diagnostic Devices market, which grew at a compound annual growth rate (CAGR) of 10.29% from 2020 to 2023, reaching a value of USD 7.57 billion in 2023. It is projected that the market will grow to USD 17.65 billion by 2030.

Bruker (BRKR) Up 6.8% Since Last Earnings Report: Can It Continue?
Bruker (BRKR) Up 6.8% Since Last Earnings Report: Can It Continue?
Bruker (BRKR) Up 6.8% Since Last Earnings Report: Can It Continue?
BRKR
zacks.comSeptember 5, 2024

Bruker (BRKR) shared its earnings report 30 days ago. What can we expect for the stock moving forward?

Should You Consider Retaining Bruker Stock in Your Portfolio Now?
Should You Consider Retaining Bruker Stock in Your Portfolio Now?
Should You Consider Retaining Bruker Stock in Your Portfolio Now?
BRKR
zacks.comAugust 30, 2024

BRKR shows strong growth potential in its key areas, which is promising. However, economic issues and competition may create difficulties.

Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
BRKR
globenewswire.comAugust 29, 2024

Biognosys has partnered with Alamar Biosciences to offer NULISA multiplex assay services for biopharma research. Their NULISAseq™ CNS Disease and Inflammation panels are now available as a contract research service from their advanced proteomics facility in Europe. This combination of NULISA assays and TrueDiscovery® mass spectrometry provides comprehensive solutions for plasma proteomics, making Biognosys a leader in next-generation proteomics for drug discovery and development.

Bruker (BRKR) Rolls Out the First 1.2 GHz NMR System in Asia
Bruker (BRKR) Rolls Out the First 1.2 GHz NMR System in Asia
Bruker (BRKR) Rolls Out the First 1.2 GHz NMR System in Asia
BRKR
zacks.comAugust 16, 2024

Bruker (BRKR) has set up the 1.2 GHz Avance NMR Spectrometer at KBSI, which will help in making important scientific discoveries.

FAQ

  • What is the ticker symbol for Bruker?
  • Does Bruker pay dividends?
  • What sector is Bruker in?
  • What industry is Bruker in?
  • What country is Bruker based in?
  • When did Bruker go public?
  • Is Bruker in the S&P 500?
  • Is Bruker in the NASDAQ 100?
  • Is Bruker in the Dow Jones?
  • When was Bruker's last earnings report?
  • When does Bruker report earnings?
  • Should I buy Bruker stock now?

What is the ticker symbol for Bruker?

The ticker symbol for Bruker is NASDAQ:BRKR

Does Bruker pay dividends?

Yes, Bruker pays dividends. The last payment was $0.05, with an ex-dividend date on December 2, 2024

What sector is Bruker in?

Bruker is in the Healthcare sector

What industry is Bruker in?

Bruker is in the Medical Devices industry

What country is Bruker based in?

Bruker is headquartered in United States

When did Bruker go public?

Bruker's initial public offering (IPO) was on August 4, 2000

Is Bruker in the S&P 500?

No, Bruker is not included in the S&P 500 index

Is Bruker in the NASDAQ 100?

No, Bruker is not included in the NASDAQ 100 index

Is Bruker in the Dow Jones?

No, Bruker is not included in the Dow Jones index

When was Bruker's last earnings report?

Bruker's most recent earnings report was on Nov 5, 2024

When does Bruker report earnings?

The next expected earnings date for Bruker is Feb 13, 2025

Should I buy Bruker stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions